Antiviral compounds from plants

Antiviral Compounds From Plants

Volumn , Issue , 2018, Pages 1-200

  Hudson, James B ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85051156148     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781351069724     Document Type: Book

References (498)

1. Mohanty, S. B. and Dutta, S. K., Veterinary Virology, Lea and Febiger, Philadelphia, 1981.
2. Gibbs, E. P. J., Ed., Virus Disease of Food Animais, Vol. 2, Academic Press, New York, 1986.
3. White, D. G. and Fenner, F. J., Medicai Virology, 3rd ed., Academic Press, New York, 1986.
4. Hansen, A. J., Chemotherapy of plant virus infections, in Applied Virology Research, Vol. 1, Kurstak, E., Marusyk, R. G., Murphy, F. A., and Van Regenmortel, M. H. V., Eds., Plenum Press, New York, 1988, chap. 21.
5. Callis, J. J., Poppensieck, G. C., and Ferris, D. H., Surveillance and control of virus diseases: Americas, in Virus Disease of Food Animais, Vol. 1, Gibbs, E. P. J., Ed., Academic Press, New York, 1981.
6. King, A. M. Q., Underwood, B. O., McCahon, D., Newman, J. W. I., and Brown, F., Biochemical identification of viruses causing the 1981 outbreaks of foot and mouth disease in the U.K., Nature, 293, 479, 1981.
7. Brooksby, J. B., Tracing outbreaks of foot-and-mouth disease, Nature, 293, 431, 1981.
8. Pereira, H. G., Foot and mouth disease, in Virus Diseases of Food Animais, Vol. 2, Gibbs, E. P. J., Ed., Academic Press, New York, 1981.
9. Brown, F., The principal animal virus diseases and their economic importance, Buli. Inst. Pasteur, 80, 153, 1981.
10. Murphy, F. A., Rabies pathogenesis, brief review, Arch. Virol., 54, 279, 1977.
11. Norrby, E., Virai vaccines: the use of currently available products and future developments, Arch. Virol., 76, 163, 1983.
12. Koprowski, H., Rabies, in Conceptsin Virai Pathogenesis, Notkins, A. L., Oldstone, M. B. A.,Eds., Springer- Verlag, Berlin, 1984, 344.
13. Pilcher, K. S. and Fryer, J. L., The virai diseases of fish. A review through 1978, CRC Crit. Rev. Microbiol., 1, 1980.
14. Wolf, K., Newly discovered viruses and virai diseases of fishes, 1977—1981, in Microbial Disease of Fish, Roberts, R. J., Ed., Academíc Press, New York, 1982.
15. Hetrick, F. M., Knittel, M. D., and Fryer, J. L., Increased susceptibility of rainbow trout to infectious hematopoietic necrosis virus after exposure to copper, Appl. Environ. Microbiol., 37, 198, 1979.
16. Wedemeyer, G. A., McLeay, D. J., and Goodyear, C. P., Assessing the tolerance of fish and fish populations to environmental stress: the problems and methods of monitoring, in Contaminant Effects of Fisheries, Vol. 12 John Wiley & Sons, 164, 1984.
17. Hetrick, F. M., Fryer, J. L., and Knittel, M. D., Effect of water temperature on the infection of rainbow trout Salmo gairdneri Richardson with infectious haematopoietic necrosis virus, J. Fish. Dis., 2, 253, 1979.
18. Traxler, G. S., A survey for infectious hematopoietic necrosis virus in adult sockeye salmon (Oncorhyncus nerka) in great central lake, B.C., Can. Tech. Rep. Fish Aquat. Sei., 1205, 1983.
19. Hasobe, M. and Saneyoshi, M., On the approach to the virai chemotherapy against infectious hematopoietic necrosis virus (INV) in vitro and in vivo on salmonid fishes, Fish. PathoL, 20, 243, 1983.
20. Hudson, J. B., Graham, E. A., and Simpson, M. F., The efficacy of amantadine and other antiviral compounds against two salmonid viruses in vitro, Antivir. Res., 9, 379, 1988.
21. Leong, J. C. and Barila, T. Y., Eds., Proc. Workshop on Virai Diseases of Salmonid Fishes in the Columbia River Basin, Bonneville Power Admin., Portland, OR, 1982.
22. White, D. O., and Fenner, F. J., Medical Virology, 3rd ed., Academic Press, New York, 1986, chap. 19.
23. Rueckert, R. R., Picomaviruses and their replication, in Virology, Fields, B. N., Ed., Raven Press, New York, chap. 32.
24. Vanden Berghe, D. A., Vlietinck, A. J. and Van Hoof, L., Present status and prospects of plant produets as antiviral agents, Advances in Medicinal Plant Research, Vlietinck, A. J. and Dommisse, Ed., Wissenschaftli- che Verlagsgesellschaft Stuttgart, 1985.
25. Hess, W. R., African swine fever: a reassessment, Adv. Vet. Sei. Comp. Med., 25, 39, 1981.
26. Wilkinson, P. J., African swine fever, in Virus Disease of Food Animais, Vol. 2, Gibbs, E. P. J., Ed., Academic Press, New York, 1981.
27. Vinuela, E., African swine fever virus, in Concepts in Virai Pathogenesis II, Notkins, A. L. and Oldstone, M. B. A., Eds., Springer-Verlag, Berlin, 1986, chap. 28.
28. Hollinger, F. B. and Melnick, J. L., Virai hepatitis, in Virology, Fields, B. H., Ed., Raven Press, New York, 1985, chap. 59.
29. Hollinger, F. B. and Robinson, W. S., Hepatitis viruses and their replication, in Virology, Fields, B. N„ Ed., Raven Press, New York, chap. 60.
30. Lancaster, J. E., Newcastle disease, in Virus Diseases of Food Animais, Vol. 2, Gibbs, E. P. J., Ed., Academic Press, New York, 1981.
31. Scott, F., Rinderpest, in Virus Diseases ofFood Animais, Vol. 2, Gibbs, E. P. J., Ed., Academic Press, New York, 1981.
32. Schild, G. C., Molecular and genetic aspects of variation in influenza viruses: implications for control of the disease, in Control of Virus Diseases, Kurstak, E. and Marusyk, R. G., Eds., Mareei Dekker, New York, 1984.
33. Murphy, B. R. and Webster, R. G., Influenza viruses, in Virology, Fields, B. N., Ed., Raven Press, New York, 1985, chap. 51.
34. Oxford, J. S. and Galbraith, A., Anti-influenza virus activity of amantadine: a selective review of laboratory and clinicai data, in Virai Chemotherapy, Vol. 1, Shugar, D., Ed., Pergamon Press, New York, 1984.
35. Roizman, B. and Batterson, W., Herpesviruses and their replication, in Virology, Fields, B. N., Ed., Raven Press, New York, 1985, chap. 25.
36. Rawls, W. E., Herpes simplex virus, in Virology, Fields, B. N., Ed., Raven Press, New York, 1985, chap. 26.
37. Griffiths, P. D. and Grundy, J. E., Molecular biology and immunology of cytomegalovirus, Biochem. J., 241, 313, 1987.
38. Alford, C. A. and Britt, W. J., Cytomegalovirus, in Virology, Fields, B. N., Ed., Raven Press, New York, 1985, Chap. 29.
39. Gelb, L. D., Varicella-zoster virus, in Virology, Fields, B. N., Ed., Raven Press, New York, 1985, chap. 27.
40. Josephs, J. F., Salahuddin, S. Z., Ablashi, D. V., Schachter, F., Wong-Staal, F., and Gallo, R. C., Genomic analysis of the human B-lymphotropic virus (HBLV), Science, 234, 601, 1986.
41. Lopez, C., Pellett, P., Stewart, J., Goldsmith, C., Sanderlin, K., Black, J., Warfield, D., and Feorino, P., Characteristics of human herpesvirus 6, J. Infect. Dis., 157, 1271, 1988.
42. Ludwig, H., Herpesviruses of bovidae: the characterization, grouping and role of different types, including latent viruses, in Latent Herpesviruses in Veterinary Medicine, Wittmann, G. et al., Eds., Martinus Nijhoff, The Hague, 1984.
43. Burrows, R. and Goodridge, D., Studies of persistent and latent equid herpesvirus I and herpesvirus 3 infections in the Pirbright pony herd, in Latent Herpesviruses in Veterinary Medicine, Wittmann, G. et al., Eds., Martinus Nijhoff, The Hague, 1984.
44. Payne, L.N., Biology of Marek’s disease virus and herpesvirus of turkeys, in The Herpesviruses, Vol. 1, Roizman, B., Ed., Plenum Press, New York, 1982.
45. Wolf, K., Fish virai disease in North America, 1971—75, Fish. Pathol., 10, 135, 1976.
46. Wolf, K., Fish viruses: their biology, classification, hosts, pathology and control, in Control of Virai Disease, Kurstak, E. and Marusyk, R. G., Eds., Mareei Dekker, New York, 1984.
47. Sellers, R. F., Bluetongue and related diseases, in Virus Diseases of Food Animais, Vol. 2, Gibbs, E. P. J., Ed., Academic Press, New York, 1981.
48. Luedke, A. J., Jones, R. H., and Walton, T. E., Overwintering mechanism for bluetongue virus: biological recovery of latent virus from bovines by bites of Culicoides variipennis, Am. J. Trop. Med. Hyg., 26,313,1977.
49. Kapikian, A. Z. and Chanock, R.M., Rotaviruses, in Virology, Fields, B. N., Ed., Raven Press, New York, 1985, chap. 37.
50. Flewett, T. H. and Babiuk, L. A., Prospects for rotavirus vaccines in humans and animais, in Control of Virus Diseases, Kurstak, E. and Marusyk, R. G., Eds., Mareei Dekker, New York, 1984.
51. Couch, R. B., Rhinoviruses, in Virology, Fields, B. N., Ed., Raven Press, New York, 1985, chap. 34.
52. zur Hausen, H., Human papillomaviruses: why are some types carcinogenic?, in Concepts in Virai Pathogene- sis, Vol. 2, Springer-Verlag, Berlin, 1986, chap. 34.
53. Lancaster, W. D. and Olson, C., Animal papillomaviruses, Microbiol. Rev., 46, 191, 1982.
54. Hill, B. J., Virus diseases of fish, in Virus Diseases of Food Animais, Gibbs, E. P. J., Ed., Academic Press, New York, 1981.
55. Gallo, R. C. and Montagnier, L., AIDS in 1988, Sei. Am., 259, 40, 1988.
56. Haseltine, W. A. and Wong-Staal, F., The molecular biology of the AIDS virus, Sei. Am., 259, 52, 1988.
57. Matthews, R. E. F., The classification and nomenclature of viruses, Intervirology, 16, 16, 1981.
58. Melnick, J. L., Taxonomy and nomenclature of viruses, Prog. Med. Virol., 28, 208, 1982.
59. Mathews, R. E. F., Ed., A Criticai Appraisal of Virai Taxonomy, CRC Press, Boca Raton, FL, 1983.
60. Murphy, F. A., Virus taxonomy, in Virology, Fields, B. N., Ed., Raven Press, New York, 1985, chap. 2.
61. Baltimore, D., Expression of animal virus genomes, Microbiol. Rev., 35, 235, 1971.
62. Bachrach, H. L., Comparative strategies of animal virus replication, Adv. Virus Res., 22, 163, 1978.
63. Carrasco, L. and Smith, A. E., The replication of animal viruses, in Viral Chemotherapy, Vol. 1, Shugar, D., Ed., Pergamon Press, New York, 1984.
64. Kucera, L. S. and Myrvik, Q. N., Fundamentais of Medicai Virology, 2nd ed., Lea & Febiger, Philadelphia, 1985.
65. Dimmock, N. J., Initial stages in infection with animal viruses, J. Gen. Virol., 59, 1, 1982.
66. Co, M. S., Fields, B. N., and Greene, M. I., Virai receptors serving host functions, in Concepts in Virai Pathogenesis, Notkins, A. L. and Oldstone, M. B. A., Eds., Springer-Verlag, Berlin, 1986, chap. 15.
67. Dimmock, N. J., Mechanisms of neutralization of animal viruses, J. Gen. Virol., 65, 1015, 1984.
68. Fenner, F., McAusIan, B. R., Mims, C. A., Sambrook, J., and White, D. O., The Biology of Animal Viruses, 2nd ed., Academic Press, New York, 1974, chap. 21.
69. Ackermann, M. and Wyler, R., DNA of bovine IPV-virus (BHV-1, IPV strain) in the sacral ganglia of latently-infected calves, in Latent Herpesvirus Infections in Veterinary Medicine, Wittmann, G. et al., Eds., Martinus Nijhoff, The Hague, 1984.
70. Wittmann, G., Gaskell, R. M., and Rziha, H. J., Ed., Latent Herpes Virus Infections in Veterinary Medicine, Martinus Nijhoff, The Hague, 1984.
71. Wildy, P., Field, H. J., and Nash, A. A., Classical herpes latency revisited, in Virus Persistence, Mahy, B. W. J. et al., Eds., Cambridge University Press, Cambridge, 1982.
72. Croen, K. D, Ostrove, J. M., Dragovic, L. J., Smialek, H. E., and Straus, S. E., Latent herpes simplex virus in human trigeminal ganglia, N. Engl. J. Med., 317, 1427, 1987.
73. Lewis, M. E., Warren, K. G., Jeffrey, V. M., and Schnitke, T. K., Factors affecting the recovery of latent herpes simplex virus from human trigeminal ganglia, Can. J. Microbiol., 28, 123, 1982.
74. Gaskell, R. M., Dennis, P. E., Goddard, L. E., Cocker, F. M., and Wills, J. M., Isolation of felid herpesvirus 1 from the trigeminal ganglia of latently infected cats, J. Gen. Virol., 66, 391, 1985.
75. Hudson, J. B., Hollenberg, M. J.. and Wilkie, B. J., Ultra-structural study of lesions induced in rabbit comea by herpes simplex virus types 1 and 2, J. Infect. Dis., 133, 367, 1976.
76. Hill, T. J. and Blyth, W. A., An altemative theory of herpes simplex recurrence and a possible role of prostaglandins, Lancet, 1,397, 1976.
77. Harbour, D. A., Hill, T. J., and Blyth, W. A., Recurrent herpes simplex in the mouse; inflammation in the skin and activation of virus in the ganglia following peripheral stimulation, J. Gen. Virol., 64, 1491, 1983.
78. Klein, R. J., Initiation and maintenance of latent herpes simplex virus infections: the paradox of perpetuai immobility and continuous movement, Rev. Infect. Dis., 7, 21, 1985.
79. Roizman, B. and Sears, A. E., An inquiry into the mechanisms of herpes simplex virus latency, Annu. Rev. Microbiol., 41, 543, 1987.
80. Weiss, R. A., The persistence of retroviruses, in Virus Persistence, SGM Symposium No. 33., Cambridge University Press, Cambridge, 1982.
81. Haase, A. T., Swoveland, P., Stowring, L., Ventura, P., Johnson, K. P., Norrby, E., and Gibbs, C. J., Measles virus genome in infections of the central nervous system, J. Infect. Dis., 144, 154, 1981.
82. Ter Meulen, V. and Carter, M. J., Morbillivirus persistent infections in animais and man, in Virus Persistence, SGM Symposium No. 33, Cambridge University Press, Cambridge, 1982.
83. Haase, A. T., In situ hybridization and covert virus infections, in Concepts in Virai Pathogenesis II, Notkins, A. L. and Oldstone, M. B. A., Eds., Springer-Verlag, Berlin, 1986, chap. 36.
84. Hudson, J. B., Factors involved in persistent murine cytomegalovirus infections — a review, in Latent Herpes Virus Infections in Veterinary Medicine, Wittmann, G., Gaskell, R. N., and Rziha, H. J., Eds., Martinus Nijhoff, The Hague, 1984, 127.
85. Wolf, H. and Seibl, R., Benign and malignant disease caused by EBV, J. Invest. Dermatol., 83, 885, 1984.
86. Baichwal, V. R. and Sugden, B., Latency comes of age for herpesviruses, Cell, 52, 787, 1987.
87. Wolf, K., Quimby, M. C., Carlson, C. P., and Bullock, G. L., Infectious pancreatic necrosis: selection of a virus-free stock from a population of carrier trout., J. Fish. Res. Board Can., 25, 383, 1968.
88. Yamamoto, T. and Kilistoff, J., Infectious pancreatic necrosis virus: quantification of carriers in lake populations during a 6-year period., J. Fish. Res. Board Can., 36, 562, 1979.
89. Wolinsky, J. S. and Johnson, R. T., Role of viruses in chronic neurological disease, in Comprehensive Virology, Vol. 16„ Fraenkel-Conrat, H. and Wagner, R. R., Eds., Plenum Press, New York, 1980.
90. Ter Meulen, V., Stephenson, J. R., and Kreth, H. W., Subacute sclerosing panencephalitis, in Comprehensive Virology, Vol. 18, Fraenkel-Conrat, H. and Wagner, R. R., Eds., Plenum Press, New York, 1983.
91. Walker, D. L. and Padgett, B. L., Progressive multifocal leukoencephalopathy, in Comprehensive Virology, Vol. 18, Fraenkel-Conrat, H. and Wagner, R. R., Eds., Plenum Press, New York, 1983.
92. Diener, T. O., The enigma of viroid pathogenesis, in Concepts in Virai Pathogenesis II, Notkins, A. L. and Oldstone, M. B. A., Eds., Springer-Verlag, Berlin, 1986, chap. 26.
93. Prusiner, S. B., Barry, R. A., and McKinley, M. P., Prions causing scrapie and Creutzfeld-Jacob disease, in Concepts in Virai Pathogenesis II, Notkins, A. L. and Oldstone, M. B. A., Eds., Springer-Verlag, Berlin, 1986, Chap. 26.
94. King, A. M. Q., Underwood, B. O., McCahon, D., Newman, J. W. I., and Brown, F., Biochemical identification of viruses causing the 1981 outbreaks of foot and mouth disease in the U.K., Nature, 293, 479, 1981.
95. Rweyamamu, M. W. and Ouldridge, E. J., Antigenic variation of foot-and-mouth disease virus as a factor in the control of the disease in Africa, Buli. Inst. Pasteur, 80, 157, 1982.
96. Webster, R. G., Laver, W. G., Air, G. M., and Schild, G. C., Molecular mechanisms of variation in influenza viruses, Nature, 296, 115, 1982.
97. Bean, W. J., Kawaoka, Y., Wood, J. M., Pearson, J. E., and Webster, R. G., Characterization of virulent and avirulent A/chicken/Pennsylvania/83 influenza A viruses: potential role of defective interfering RNAs in nature, J. Virol., 54, 151, 1985.
98. Schild, G. C., Molecular and genetic aspects of variation in influenza viruses: implications for control of the disease, in Control of Virus Disease, Kurstak, E. and Marusyk, R. G., Eds., Mareei Dekker, New York, 1984.
99. Webster, R. G., Campbell, C. H., and Granoff, A., The in vivo produetion of “new” influenza viruses, Virology, 51, 149, 1973.
100. Bishop, D. H. L., Replication of arenaviruses and bunyaviruses, in Virology, Fields, B. D., Ed., Raven Press, New York, 1985, chap. 46.
101. Coffin, H. M., Genetic variation in AIDS viruses, Cell, 46, 1, 1986.
102. Lott, T. J., Plikalvtis, B. D., Benson, J., Srinivasan, A., and Kalyanaraman, V. S., Three-dimensional similarity mapping reveals nucleotide sequence relationships among human immunodeficiency virus (HIV) isolates, Gene, 57, 247, 1987.
103. Vinuela, E., African swine fever virus, in Concepts in Virai Pathogenesis II, Notkins, A. L. and Oldstone, M. A., Eds., Springer-Verlag, 1986, chap. 28.
104. Waddell, G. and De Jong, J. C., Restriction endonucleases in identification of a genome type of adenovirus 19 associated with keratoconjunctivitis, Infect. Immun., 27, 292, 1980.
105. Reanney, D. C., The evolution of RNA viruses, Annu. Rev. Microbiol., 36, 47, 1982.
106. Holland, J. J., Spindler, K., Horodyski, F., Grabau, E., Nichol, S., and vandePol, S., Rapid evolution of RNA genomes, Science, 215, 1577, 1982.
107. Steinhauer, D. A. and Holland, J. J., Rapid evolution of RNA viruses, Annu. Rev. Microbiol., 41,409,1987.
108. Webster, R. G., Laver, W. G., Air, G. M., and Schild, G. M., Molecular changes in A/chicken/Pennsylvania/ 83 (H5N2) influenza virus associated with acquisition of virulence, Virology, 149, 165, 1986.
109. Leong, J. C., Hsu, J. L., Engelking, H. M., and Mulcahy, D., Strains of infectious hematopoietic necrosis (IHN) virus may be identified by structural protein differences, Dev. Biol. Stand., 49, 43, 1981.
110. Leong, J. C. and Barila, T. Y., Eds., Proc., Workshop on Virai disease of Salmonid Fishes in the Columbia River Basin, Bonneville Power Admin., Portland, OR, 1982.
111. Hsu, Y.-L., Engleking, H. M. and Leong, J. C., Occurrence of different types of infectious hematopoietic necrosis virus in fish, Appl. Environ. Microbiol., 52, 1353, 1986.
112. Domingo, E., Martinez-Salas, E., Sobrino, F., de la Torre, J. C., and Portela, A., The quasispecies (extremely heterogeneous) nature of virai RNA genome populations: biological relevance — a review, Gene, 1, 1985.
113. Eigen, M., Self replication and molecular evolution, in Evolution from Molecules to Man, Bendall, D. S., Ed., Cambridge University Press, Cambridge, 1983, 105.
114. Mills, D. R., Peterson, R. L. and Spiegelman, S., An extracellular Darwinian experiment with a self- duplicating nucleic acid molecule, Proc. Natl. Acad. Sei. U.S.A., 58, 217, 1967.
115. McCauley, J. W., Influenza virus glycoprotein variation and its role in disease, in Molecular Basis of Virus Disease, Russell, W. C. and Almond, J. W., Eds., Cambridge University Press, Cambridge, 1987.
116. McLean, D. M., Arboviruses, in Virology in Health Care, Williams & Wilkins, Baltimore, 1980, chap. 11.
117. Pereira, H. G., Foot and mouth disease, in Virus Diseases of Food Animais, Vol. 2, Gibbs, E. P. J., Ed., Academic Press, New York, 1981.
118. Burrows, R. and Goodridge, D., Studies of persistent and latent equid herpesvirus 1 and herpesvirus 3 infections in the Pirbright pony herd, in Latent Herpesvirus Infections in Veterinary Medicine, Wittmann, G., Gaskell, R. W., and Rziha, H. J., Eds., Martinus Nijhoff, The Hague, 1984.
119. Wolf, K., Advances in fish virology: a review 1966—71, Symp. Zool. Soc. Lond., 30, 605, 1972.
120. Pilcher, K. S. and Fryer, J. L., The virai diseases of fish. A review through 1978, CRC Crit. Rev. Microbiol., 1, 1980.
121. Pilcher, K. S. and Fryer, J. L., The virai diseases of fish. A review through 1978, Crit. Rev. Microbiol., 8, Part 2, 1, 1980.
122. Hudson, J. B., The murine cytomegalovirus as a model for the study of virai pathogenesis and persistent infections, Arch. Virol., 62, 1, 1979.
123. Hudson, J. B., Animal viruses of economic importance: genetic variation, persistence and prospects for their control, Pharmacol. Ther., 30, 115, 1985.
124. Weiss, R. A., Molecular and cellular aspects of retrovirus pathogenicity, in Molecular Basis of Virus Disease, Russell, W. C. and Almond, J. W., Eds., Cambridge University Press, Cambridge, 1987.
125. Kaaden, O. R. and Lange, S., Virology, immunology, epidemiology and control of enzootic bovine leukosis, in Control of Virus Diseases, Kurstak, E. and Marusyk, R. G„ Eds., Mareei Dekker, New York, 1984.
126. Eaglesome, M. D., Hare, W. C. D., and Singh, E. L., Embryo transfer: a discussion on its potential for infectious disease control based on a review of studies on infection of gametes and early embryos by various agents, Can. Vet.J., 21, 106, 1980.
127. Bowen, R. A., Howard, T. H., Entwistle, K. W., and Pickett, B. W., Seminal shedding of bluetongue virus in experimentally infected mature bulis, Am. J. Vet. Res., 44, 2268, 1983.
128. Phillips, S. M., Stephenson, J. R., and Aaronson, S. A., Genetic factors influencing mouse type-C RNA virus induetion by naturally occurring B cell mitogens, J. Immunol., 118, 662, 1977.
129. Rapp, U. F. and Todaro, G. J., Generation of new mouse sarcoma viruses in cell culture, Science, 201, 821, 1978.
130. Seeley, R. J., Perlmutter, A., and Seeley, V. A., Inheritance and longevity of infectious pancreatic necrosis virus in the zebra fish, Brachydano rerio (Hamilton-Buchanan), Appl. Environ. Microbiol., 34, 50, 1977.
131. Lancaster, J. E., Newcastle disease, in Virus Diseases of Food Animais, Vol. 2, Gibbs, E. P. J., Ed., Academic Press, New York, 1981.
132. Laver, W. G. and Webster, R. G., Ecology of influenza viruses in lower mammals and birds, Br. Med. Buli, 29, 1979.
133. Sonstegard, R. A. and McDermott, L. A., Epidemiological model for passive transfer of IPNV by homeotherms, Nature, 237, 104, 1972.
134. Crick, J., Rabies, in Virus Diseases of Food Animais, Vol. 2, Gibbs, E. P. J., Ed., Academic Press, New York, 1981.
135. Wilkinson, P. J., African swine fever, in Virus Diseases of Food Animais, Vol. 2, Gibbs, E. P. J., Ed., Academic Press, New York, 1981.
136. Sellers, R. F., Bluetongue and related disease, in Virus Diseases of Food Animais, Vol. 2, Gibbs, E. P. J., Ed., Academic Press, New York, 1981.
137. Peters, C. J. and Johnson, K. M., Hemorrhagic fever viruses, in Concepts in Virai Pathogenesis, Notkins, A. L. and Oldstone, M. B. A., Eds., Springer-Verlag, Berlin, 1984.
138. Hinshaw, V. S., Webster, R. G., and Turner, B., Novel influenza A viruses isolated from Canadian feral ducks, J. Gen. Virol., 41,115, 1978.
139. Norrby, E., Virai vaccines: the use of currently available products and future developments, Arch. Virol., 76, 163, 1983.
140. Mitchell, C. D. and Balfour, H. H., Measles control: so near and yet so far, Prog. Med. Virol, 31, 1, 1985.
141. Prusoff, W. H., Lin, T.-S., and Zucker, M., Potential targets for antiviral therapy, Antiviral Sei., 6, 31, 1986.
142. Henderson, J. F., Effects of antiviral nucleoside analogs on purine metabolism, in Virai Chemotherapy, Vol. 2 Shugar, D., Ed., Pergamon Press, New York, 1985.
143. Loddo, B. and LaCoIla, P., Development of drug resistance and dependance in viruses, in Virai Chemotherapy, Vol. 2, Shugar, D., Ed., Pergamon Press, New York, 1985.
144. Larder, B. A. and Darby, G., Virus drug-resistance: mechanisms and consequences, AntiviralRes., 4, 1, 1984.
145. Rosen, A., Ernst, F., Koch, H.-G., Gelderblom, H., Darai, G., Hadar, H., Tahor, E., Ben-Hur, T., and Becker, Y., Replacement of the deletion in the genome (0.762—0.789 mu) of avirulent HSV-1 HFEM using cloned MLul DNA fragments (0.7616—0.796mu) of virulent HSV-1 F leads to generation of virulent intratypic recombinant, Virus Res., 5, 157, 1986.
146. Gauri, K. K., HSV mutants and antiviral drugs, in Antiviral Chemotherapy: Design of lnhibitors of Virai Function, Ganon, K. K., Ed., Academic Press, New York, 1981.
147. Yarchau, R. and Broder, S., Development of antiretroviral therapy for the acquired immunodeficiency syndrome and related disorders: a progress report, N. Engl. J. Med., 316, 557, 1987.
148. Mitsuya, M. and Broder, S., Strategies for antiviral therapy in AIDS, Nature, 325, 773, 1987.
149. Cohen, S. S., The mechanisms of inhibition of cellular and virai multiplication by aranucleosides and aranucleotides, in Nucleoside Analogues — Chemistry and Medicai Applications, Walker, R. T. et al., Eds., Plenum Press, New York, 1979.
150. Pavan-Langston, D. R., Ocular virai disease, in Antiviral Agents and Virai Disease ofMan, Galasso, G. J. et al., Eds., Raven Press, New York, 1984.
151. Bockstahler, L. E., Hellman, K. B., Lytle, C. D., and Roberts, J. E., Criticai review and risk evaluation of photodynamic therapy for herpes simplex, in Virai Chemotherapy, Shugar, D., Ed., Pergamon Press, New York, 1984.
152. Wolff, K. and Hònigsmann, H., Clinicai aspects of photochemotherapy, Pharmacol. Ther., 12, 381, 1981.
153. Hollenberg, M. J., Wilkie, J. S., Hudson, J. B., and Lewis, B. J., Morphology of lesions produced by human herpesvirus 1 and 2 in rabbit corneai epithelium, Arch. Ophthalmol., 94, 127, 1976.
154. Rapp, F., Li, J. H., and Jerkofsky, M., Oncogenic potential of herpes simplex virus in mammalian cells following photodynamic inactivation, Photochem. Photobiol, 25, 335, 1973.
155. Piette, J., Merville-Louis, M.-P., and Decuyper, J., Damages induced in nucleic acids by photosensitization, Photochem. Photobiol., 44, 973, 1986.
156. Spikes, J. D., Porphyrins and related compounds as photodynamic sensitizers, Ann. N. Y. Acad. Sei. U.S.A., 176, 496, 1975.
157. Towers G. H. N., Photosensitizers in plants and their photodynamic action (a review), Prog. Phytochem., 6, 183, 1980.
158. Towers G. H. N., Interactions of light with phytochemicals in some natural and novel systems, Can. J. Bot., 2900, 1984.
159. Poulton, G. A. and Ashwood-Smith, M. J., Photosensitizing plant produets, in Carcinogens and Mutagens in the Environment, Naturally Occurring Compounds: Epidemiology andDistribution, Vol. 3, Stich, H. F., Ed., CRC Press, Boca Raton, FL, 1983, 87.
160. Towers G. H. N. and Hudson, J. B., Potentially useful antimicrobial and antiviral phototoxins from plants, Photochem. Photobiol., 46, 61, 1987.
161. Edwards, D. C., Targeting potential of antibody conjugates, Pharmacol. Ther., 23, 147, 1983.
162. Magee, W. E. and Ristow, S. S., Targeting to lymphoid cells of the immune network, Pharmacol. Ther., 21, 295, 1983.
163. Vitetta, E. S., Krolick, K. A., Miyama-Inaba, M., Cushley, W., and Uhr, H. W., Immunotoxins: a new approach to cancer therapy, Science, 219, 644, 1983.
164. Oseroff, A. R., Ara, G., Ohueoha, D., Aprille, H., Bommer, J. C., Yarmush, M. L., Foley, J., and Cincotta, A., Strategies for selective cancer photochemotherapy: antibody-targeted and selective carcinoma cell photolysis, Photochem. Photobiol., 46, 83, 1987.
165. Mew, D., Wat, C.-K., Towers G. H. N., and Levy, J. G., Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates, J. Immunol., 130, 1473, 1983.
166. Dougherty, T. J. and Mang, T. S., Characterization of intra-tumoral porphyrin following injection of hematoporphyrin derivative or its purified component, Photochem. Photobiol., 46, 67, 1987.
167. Vanden Berghe, D. A., Vlietinck, A. J., and Van Hoof, L., Present status and prospects of plant products as antiviral agents, in Advances in Medicinal Plant Research, Vlietinck, A. J. and Dommisse, Eds., Wissen- schaftliche Verlagsgesellschaft, MbH, Stuttgart, 1985.
168. Vanden Berghe, D. A., Vlietinck, A. J., and Van Hoof, L., Plant products as potential antiviral agents, Buli. Inst. Pasteur, 84, 101, 1986.
169. Dargan, D. J. and Subak-Sharpe, J. H., The effect of triterpenoid compounds on uninfected and herpes simplex virus-infected cells in culture. I, Effect on cell growth, virus particles and virus replication, J. Gen. Virol., 66, 1771, 1985.
170. Pauwels, R., De Clercq, E., Desmyter, J., Balzarini, J., Goubak, P., Herdewijn, P., Vanderhaeghe, H., and Vanderputte, M., Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus, J. Virol. Meth., 16, 171, 1987.
171. Oldstone, M. B. A., Rodriguez, M., Daughaday, W. H., and Lampert, P. W., Virai perturbation of enzyme function: disorder of cell function leading to disturbed homeostasis and disease, Nature, 307, 278, 1984.
172. Walder R. Y. and Walder, J. A., Role of RNase H in hybrid-arrested translation by antisense oliogonucleotides, Proc. Natl. Acad. Sei. U.S.A., 85, 5011, 1988.
173. Hudson, J. B., The problem of host DNA synthesis in murine cytomegalovirus-infected cells, Virology, 101, 545, 1980.
174. Muller, M. T., Cell Cycle Dependant Replication of the Murine Cytomegalovirus, Ph.D. thesis, University of B.C., Vancouver, 1977
175. Vanden Berghe, D. A., Ieven, M. A., Mertens, F., and Vlietinck, A. J., Screening of higher plants for biological activities. II. Antiviral activity, J. Natl. Prod., 41, 463, 1978.
176. Farnsworth, N. R., Henry, L. K., Svoboda, G. H., Blomster, R. N., Yates, M. J., and Euler, K. L., Biological and phytochemical evaluation of plants. I. Biological test procedures and results from two hundred accessions, J. Natl. Prod., 29, 101, 1966.
177. Vanden Berghe, D. A., Vlietinck, A. J., and Van Hoof, L., Present status and prospects of plant products as antiviral agents, Advances in Medicai Plant Research, Vlietinck, A. J. and Dommisse, Eds., Wissenschaftliche Verlagsgesellschaft, MbH, Stuttgart, 1985.
178. Prusoff, W. H., Lin, T.-S., and Zucker, M., Potential targets for antiviral chemotherapy, Antiviral Res., 6, 311, 1986.
179. Harborne, J. B., Phytochemical Methods, Chapman and Hall, London, 1973.
180. Robinson, T., The Organic Constituents of Higher Plants, 5th ed., Cordus Press, North Amherst, MA, 1983
181. Turro, N. J. and Lamola, A. A., Photochemistry, in The Science of Photobiology, Smith, K. C., Ed., Plenum Press, New York, 1977, chap. 3.
182. Spikes, J. D., Photosensitization, in The Science of Photobiology, Smith, K. C., Ed., Plenum Press, New York, 1977, chap. 4.
183. Wallis, C. and Melnick, J. L., Photodynamic inactivation of animal viruses: a review, Photochem. Photobiol., 159, 1966.
184. Bockstahler, L. E., Hellman, K. B., Lytle, C. D., and Roberts, J. E., Criticai review and risk evaluation of photodynamic therapy for herpes simplex, in Virai Chemotherapy, Shugar, D., Ed., Pergamon Press, New York, 1984.
185. Poulton, G. A. and Ashwood-Smith, M. J., Photosensitizing plant products, in Carcinogens and Mutagens in the Environment, Vol. 3, Stich, H. F., Ed., CRC Press, Boca Raton, FL, chap. 9.
186. Towers G. H. N., Interactions of light with phytochemicals in some natural and novel systems, Can. J. Bot., 62,2900, 1984.
187. Pathak, M. A., Pitzpatrick, T. B., Parrish, J. A.,and Biswas, R., Photochemotherapeutic, photobiological and photochemical properties of psoralens, in Research in Photohiology, Castellan, A., Ed., Plenum Press, New York, 1977.
188. Song, P. S. and Tapley, K. J., Photochemistry and photobiology of psoralens, Photochem. Photobiol., 29, 1 177, 1979.
189. Hearst, J. E., Psoralen photochemistry, Annu. Rev. Biophys. Bioeng., 10,69, 1981.
190. Cimino, G. D., Camper, H. B., Isaacs, S. T., and Hearst, J. E., Psoralens as photoactive probes of nucleic acid structure and function: organic chemistry, photochemistry, and biochemistry, Annu. Rev. Biochem., 54, 1151, 1985.
191. Ashwood-Smith, M. J., Poulton, G. A., Barker, M., and Mildenberger, M., 5-Methoxypsoralen, an ingredient in several suntan preparations, has lethal, mutagenic and clastogenic properties, Nature, 285,407, 1980.
192. Ashwood-Smith, M. J., Natarajan, A. T., and Poulton, G. A., Comparative photobiology of psoralens, J. Natl. Cancer Inst.. 69, 189, 1982.
193. Grekin, D. A. and Epstein, J. H., Psoralens, UVA (PUVA) and photocarcinogenesis, Photochem. Photobiol., 33, 957, 1981.
194. Ivie, G. W., Chemical and biochemical aspects of photosensitization in livestock and poultry, J. Natl. Cancer Inst.. 69, 259, 1982.
195. Hassan, M. A. and Zubair, M. U., Khellin, in Analytical Profiles of Drug Substances, 1980, chap. 9.
196. Abdel-Fattah, A., Aboul-Eneim, M. N., Wassel, G. M., and El-Menshawi, B. S., An approach to the treatment of Vitiligo by Khellin, Dermatologica, 165, 136, 1982.
197. Cassuto, E., Gross, N., Bardwell, E., and Howard-Flanders, P., Genetic effects of photoadducts of photocross-links in the DNA of phage lambda exposed to 360 nm light and trimethylpsoralen or khellin, Biochim. Biophys. Acta, 475, 589, 1977.
198. Altamirano-Dimas, M., Hudson, J. B., Abramowski, Z., and Towers G. H. N., The photoinduction of DNA cross-links by the furanochromone visnagin, Photochem. Photobiophys., 10, 121, 1985.
199. Colombo, G., Levis, A. G., and Toulone, V., Photosensitization of mammalian cells and of animal viruses by furocoumarins, Prog. Biochem. Pharmacol., 1, 392, 1965.
200. Musajo, L., Rodighiero, G., Colombo, J., Toulone, V., and Dall-aqua, F., Photosensitizing furocoumarins: interactions with DNA and photoinactivation of DNA containing virus, Experientia, 21, 22, 1965.
201. Hearst, J. E. and Thiry, L., The photoinactivation of an RNA animal virus, vesicular stomatitis virus, with the aid of newly synthesized psoralen derivatives, Nucl. Acid Res., 4, 1339, 1977.
202. Hanson, C. V., Riggs, J. L., and Lennette, E. H., Photochemical inactivation of DNA and RNA viruses by psoralen derivatives, J. Gen. Virol., 40, 345, 1978.
203. Redfield, D. C., Richman, D. D., Oxman, M. N., and Kronenberg, L. H., Psoralen inactivation influenza and herpes simplex viruses and of virus-infected cells, Infect. Immun., 32, 1216, 1981.
204. Hudson, J. B., Graham, E. A., Chan, G. C., and Towers G. H. N., Differential effects of photoactive furanyl compounds on virus functions, Photochem. Photobiol., 42, 523, 1985.
205. Hudson, J. B., Animal viruses of economic importance: genetic variation, persistence, and prospects for their control, Pharmacol. Ther., 30, 115, 1985.
206. Harrison, S., Principles of virus structure, in Virology, Fields, B. N., Ed, Raven Press, New York, 1985, chap.3.
207. Isaacs, S. T., Shen, C.-K., Hearst, J. E., and Rapoport, H., Synthesis and characterization of new psoralen derivatives with superior photoreactivity with DNA and RNA, Biochemistry, 16, 1058, 1977.
208. Kondoleon, S. K., Walter, M. A., and Hallick, L. M., Kinetics of simian virus 40 and lambda inactivation by photaddition of psoralen derivatives, Photochem. Photobiol., 36, 325, 1982.
209. Day, R. S., Giuffrida, A. S., and Dingman, C. W., Repair by human cells of adenovirus-2 damaged by psoralen plus near ultraviolet light treatment, Murat. Res., 33, 31 1, 1975.
210. Hall, J. D., Repair of psoralen-induced cross-links in cells multiply infected with SV40, Mol. Gen. Genet., 188, 135, 1982.
211. Fendrick, J. L. and Hallick, L. M., Psoralen photoinactivation of herpes simplex virus: monoadduct and cross-links repair by xerodema pigmentosum and Fanconi's Anemia cells, J. Invest. Dermatol., 83, 96s, 1984.
212. Lytle, C. D., Tarone, R. E., Barrett, S. F., Wirtschafter, J. D., Dupuy, J.-M., and Robbins, J. H., Host cell reactivation by fibroblasts from patients with pigmented degeneration of the retina, Photochem. Photobiol., 37, 503, 1983.
213. Moore, S. P., Blount, H., and Coohill, T. P., SV40 induction from a mammalian cell line by ultraviolet radiation and the photosensitizers 8-methoxypsoralen and angelicin, Photochem. Photobiol., 37, 665, 1983.
214. Kittler, L., Hradecna, Z., and Suhnel, J., Cross-link formation of phage lambda DNA in situ photochemically induced by the furocoumarin derivative angelicin, Biochim. Biophys. Acta, 607, 215, 1980.
215. Hradecna, Z. and Kittler, L., Photobiology of furocoumarins: various types of crosslinks with DNA and their interference with the development of lambda phage, Acta Virol., 26, 305, 1982.
216. Hudson, J. B., Fong, R., Altamirano, M., and Towers G. H. N., Comparative anti-bacteriophage activity of naturally-occurring photosensitizers, Planta Med., 53, 536, 1988.
217. Altamirano, M., Hudson, J. B., and Towers G. H. N., Induction of cross-links in viral DNA by naturallyoccurring photosensitizers, Photochem. Photobiol., 44, 187, 1986.
218. Hudson, J. B., Graham, E. A., Hudson, L. L., and Towers G. H. N., The mechanism of antiviral phototoxicity of the furanochromones Visnagin and Khellin, Planta Med., 54, 131, 1988.
219. Hudson, J. B., Miki, N., and Towers G. H. N., Isopimpinellin is not phototoxic to viruses and cells, Planta Med., 53, 306, 1987.
220. Vander Sluis, W. G., Van Arker, J., Fischer, F. C., and Labadie, R. P., Thin layer chromatographic assay of photoactive compounds (furocoumarins) using the fungus Penicillium expansum as a test organism. J. Chromatogr., 214, 349, 1981.
221. Marchant, Y. Y., Turjman, M., Flynn, T., Balza, F., Mitchell, J. C., and Towers G. H. N., Identification of psoralen, 8-methoxypsoralen, isopimpinellin, and 5,7-dimethoxycoumarin in Pelea anisata H. Mann, Contact Derm., 12, 196, 1985.
222. Abel, G., Erdelmeier C., Meier, B., and Sticher, O., Iso-pimpinelin, ein furanocumarin aus Heracleum spondylium mit chromosenschodigender activitat, Planta Med., 51, 250, 1985.
223. Vos, J. M., Ganesan, A. K., Spivak, G., and Hanawalt, P. C., Psoralen monoadducts and crosslinks stimulate plasmid-mediated transformation of human cells, Photochem. Photobiol., 41s, 905, 1985.
224. Granger, M, Toulme, F., and Helene, C., Photodynamic inhibition of E. col; DNA polymerase I by 8-methoxypsoralen plus near ultraviolet irradiation, Photochem. Photohiol., 36, 175, 1982.
225. Joshi, P. C. and Pathak, M. A., Production of singlet oxygen and superoxide radicals by psoralens and their biological significance, Biochem. Biophys. Res. Commun., 112, 638, 1983.
226. Decuyper-Debergh, D., Piette, J., and Vande Vorst, A., Mutagenesis in the lac operon induced by singlet oxygen, Photochem. Photohiol., 435,605, 1986.
227. Piette, J., Merville-Louis, M. P., and Decuyper, J., Damages induced in nucleic acids by photosensitization, Photochem. Photobiol., 44, 793, 1986.
228. Specht, K. G., Kittler, L., and Midden, W. R., A new biological target of furocoumarins: photochemical formation of covalent adducts with unsaturated fatty acids, Photochem. Photobiol., 47, 537, 1988.
229. Laskin, J. D., Lee, E., Yurkow, E. J., Laskin, D. L., and Gallo, M. A., A possible mechanism of psoralen phototoxicity not involving direct interaction with DNA, Proc. Natl. Acad. Sci. U.S.A., 82, 6158, 1985.
230. Nielsen, P. E. and Bohr, V., Phototoxic effects of four psoralens on L1210 cells. The correlation with DNA interstrand cross-linking, Photochem. Photohiol., 38, 653, 1983.
231. Laskin, J. D., Lee, F., Laskin, D. L., and Gallo, M. A., Psoralens potentiate ultraviolet light-induced inhibition of epidermal growth factor binding, Proc. Natl. Acad. Sci. U.S.A., 83, 821 1, 1986.
232. Abysekera, B. F., Abramowski, Z., and Towers G. H. N., Genotoxicity of the natural furanochromones, khellin and visnagin and the identification of a khellin-thymine photoadduct, Photochem. Photohiol., 38, 3 11, 1983.
233. Goodwin, T. W. and Mercer, E. I., Introduction to PlantBiochemistry, 2nd ed., Pergamon Press, New York, 1983, chap. 13.
234. Melchior, C. and Collins, M. A., The route and significance of endogenous synthesis of alkaloids in animais, CRC Crit. Rev. Toxicol, 9, 313, 1982.
235. Rommelspacher, H., Strauss, S., and Lindstrom, J., Excreting tetrahydroharmane and harmane into the urine of man and rat after a load with ethanol, FEBS Lett., 109, 209, 1980.
236. Smythies, J. R. and Autun, F., Binding of tryptamine and allied compounds to nucleic acids, Nature (London), 223, 1061, 1969.
237. Duportail, G. and Lami, H., Studies of the interaction of the fluorophores harmine and harmaline with calf thymus DNA, Biochim. Biophys. Acta, 402, 20, 1975.
238. Hayashi, K., Nagao, M., and Sugimura, T., Interactions of norhaman and harman with DNA, Nucl. Acid. Res., 4, 3679, 1977.
239. McKenna, D. J. and Towers G. H. N., Ultra-violet mediated cytotoxic activity of 3-carboline alkaloids, Phytochemistry, 20, 1001, 1979.
240. Towers G. H. N. and Abramowski, Z., UV-mediated genotoxicity of furanoquinoline and of certain trytophan-derived alkaloids, J. Natl. Prod., 46, 576, 1983.
241. Altamirano, M., Hudson, J. B., and Towers G. H. N., Induction of cross-links in virai DNA by naturally- occurring photosensitizers, Photochem. Photobiol., 44, 187, 1986.
242. Hudson, J. B. and Towers G. H. N., Antiviral properties of photosensitizers, Photochem. Photobiol., 48,289, 1988.
243. Hudson, J. B., Graham, E. A., and Towers G. H. N., Antiviral effect of harmine, a photoactive p-carboline alkaloid, Photochem. Photobiol., 43, 21, 1986.
244. Rinehart, K. L., Kobayashi, J., Harbour, G. C., Cilmour, H., Mascai, M., Holt, T. G., Shield, L. S., and Lefarguie, F., Eudistomins A-Q, P-carbolines from the antiviral Caribbean tunicate Eudistoma olivaceum, J. Am. Chem. Soc., 109, 3378, 1987.
245. Hudson, J. B., Saboune, H., Abramowski, Z., Towers G. H. N., and Rinehart, K. L., The photoactive antimicrobial properties of eudistomins from the Caribbean tunicate Eudistoma olivaceum, Photochem. Photobiol.,Al, 377, 1988.
246. Rinehart, K. L, Kobayashi, J., Harbour, G. C., Hughes, R. G., Miszak, S. A., and Scahil, T. A., Eudistomins, C, E, K and L, potent antiviral compounds containing a novel oxathiazepine ring from the Caribbean tunicate Eudistoma olivaceum, J. Am. Chem. Soc., 106, 1524, 1988.
247. Tanrisever, N. and Towers G. H. N., unpublished results.
248. Song, P. S. and Tapley, K. J., Photochemistry and photobiology of psoralens, Photochem. Photobiol., 29, 1177, 1979.
249. Kanne, D., Straub, K., Rapoport, H., and Hearst, J. E., Psoralen-deoxyribonucleic acid photoreaction charaterization of the monaddition products from 8-methoxypsoralen and 4,5'8-trimethylpsoralen, Biochemistry, 21, 861, 1982.
250. Rodighiero, G., DalTAcqua, F., and Pathak, M. A., in Topics in Photomedicine, Smith, K. C., Ed, Plenum Press, New York, 1984, 319.
251. Gasparro, F. P., Bagel, J., and Edelson, R. L., HPLC analysis of 4',5'-monoadduct formation in calf thymus DNA and synthetic polynucleotides treated with UVA and 8-methoxypsoralen, Photochem. Photobiol.,42, 95, 1985.
252. Cimino, G. D., Gamper, H. B., Isaacs, S. T., and Hearst, J. E., Psoralens as photoactive probes of nucleic acid structure and function: organic chemistry, photochemistry, and biochemistry, Annu. Rev. Biochem., 54,1151,1985.
253. Hudson, J. B., Graham, E. A., Fong, R., Hudson, L., and Towers G. H. N., Further studies on the antiviral activity of harmine, a photoactive P-carboline alkaloid, Photochem. Photobiol., 44, 483, 1986.
254. Towers G. H. N. and Hudson, J. B., Potentially useful antimicrobial and antiviral phototoxins from plants, Photochem. Photobiol., 46,61,1987.
255. Pfyffer, G. F., Pfyffer, B. U., and Towers G. H. N., Monoaddition of dictamnine to synthetic double-stranded polydeoxyribonucleotides in UVA and the effect of photomodified DNA on template activity, Photochem. Photobiol., 35, 793, 1982.
256. Pfyffer, G. F. and Towers G. H. N., Photochemical interaction of dictamnine, a furoquinoline alkaloid, with fungai DNA in vitro and in vivo, Can. J. Microbiol., 28, 468, 1982.
257. Hudson, J. B., Graham, E. A., Chan, G. C., and Towers G. H. N., Differential effects of photoactive furanyl compounds on virai functions, Photochem. Photobiol., 42,523,1985.
258. Becker, Y., Antiviral agents from natural sources, Pharmacol. Ther., 10, 119, 1980.
259. Horwitz, M. S. and Horwitz, S. B., Intracellular degrádation of Hela and adenovirus type 2 DNA induced by camptothecin, Biochem. Biophys. Res. Commun., 45, 723, 1971.
260. Becker, Y. and Olshewsky, U., Inhibition of herpes simplex virus replication by camptothecin, Isr. J. Med. Sei.,9, 1578, 1973.
261. Rubinstein, L. and Rein, A., Effect of camptothecin on simian virus 40 DNA, Nature, 248, 226, 1974.
262. Minor, P. D. and Dimmock, N. J., Inhibition of synthesis of influenza virus proteins: evidence for two host- cell dependent events during multiplication, Virology, 67, 114, 1975.
263. Minor, P. D. and Dimmock, N. J., Selective inhibition of influenza virus protein synthesis by inhibitors of DNA function, Virology, 78, 393, 1977.
264. Kuwahara, J., Suzuki, T., Funakoshi, K., and Sugiura, Y., Photosensitive DNA cleavage and phage inactivation, Biochemistry, 25, 1216, 1986.
265. Yamazaki, Z. and Takagi, I., Antiviral effects of atropine and caffeine, J. Gen. Virol., 50, 429, 1980.
266. Biziagos, E., Crance, J.-M., Passagot, J., and Deloince, R., Effect of antiviral substanceson hepatitis A virus replication in vitro, J. Med. Virol., 22, 57, 1987.
267. Sola, A., Rodriguez, S., Gil-Fernandez, C., Alarcon, B., Gonzales, M. E., and Carrasco, L., New agents active against African Swine fever virus, Antimicrob. Agents Chemother., 29, 284, 1986.
268. Vanden Berghe, D. A., Vlietinck, A. J., and Van Hoof, L., Plant products as potential antiviral agents, Buli. Inst. Pasteur, 84, 101, 1986.
269. Schwartz, R. T. and Datema, R., Inhibitors of trimming: new tools in glycoprotein research, Trends Biochem. Sei., 9, 32, 1984.
270. Elbein, A. D., Horisberger, M., Dorling, P. R., and Vosbeck, K., Swainsonine prevents the processing of the oligosaccharide chains of influenza virus hemagglutinin, J. Biol. Chem., 257, 1573, 1982.
271. Kang, M. S. and Elbein, A. D., Alterations in the strueture of the oligosaccharide of vesicular stomatitis virus G protein by swainsonine, J. Virol., 46, 60, 1983.
272. Tulsiani, D. R. P., Harris, T. M., and Touster, O., Swainsonine inhibits the biosynthesis of complex glycoproteins by inhibition of golgi mannosidase II, J. Biol. Chem., 257, 7936, 1982.
273. Albrecht, T., Lee, C. H., Speelman, D. J., and Steinsland, O. S., Inhibition of cytomegalovirus replication by smooth-muscle relaxing agents, Proc. Soc. Exp. Biol. Med., 186, 41, 1987.
274. Sunkara, P. S., Bowlin, T. L., Lin, P. S., and Sjoerdsma, A., Antiretroviral activity of castanospermine and deoxynojirimycin, specific inhibitors of glycoprotein processing, Biochem. Biophys. Res. Commun., 148, 206, 1987.
275. Robinson, W. E., Montefiore, D. C., and Mitchell, W. M., Evidence that mannosyl residues are involved in human immunodeficiency virus type 1 (HIV-1) pathogenesis, AIDS Res. Hum. Retrov., 3, 265, 1987.
276. Walker, B. D., Kowalski, M., Goh, W. C., Kozarsky, K., Krieger, M., Rosen, C., Rohrschneider, L., Haseltine, W. A., and Sodroski, J., Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine, Proc. Natl. Acad. Sei. U.S.A., 84, 8120, 1987.
277. Montefiore, D. C., Robinson, W. E., and Mitchell, W. M., submitted.
278. Taylor, D. L. and Tyms, A. S., Inhibitors of glycoprotein-trimming enzymes block HIV and CMV growth, Antiviral Res., 152, 1988.
279. Joshi, M. N., Chowdhury, B. L., Vishnoi, S. P., Shoeb, A., and Kapil, R. S., Antiviral activity of (+)- odorinol, Planta Med., 53, 254, 1987.
280. Kovacs, E., Poliovirus produetion in Hela cells in the presence of colchicine, Experientia, 18, 70, 1962.
281. Dales, S., Association between the spindle apparatus and reovirus, Proc. Natl. Acad. Sei. U.S.A., 50,265,1963.
282. Richardson, C. D. and Vance, D. E., The effect of colchicine and dibucaine on the morphogenesis of Semliki Forest virus, J. Biol. Chem., 253, 4584, 1978.
283. Weinstein, L. and Chang, T.-W., The effect of colchicine and some chemically related compounds on experimental virai infections, Antibiot. Chemother. (Washington, D.C.), 10, 180, 1960.
284. Tokumaru, T. and Avitabule, A., Suppression of herpes simplex virus infection by antimitotic substances in the rabbit comea, Proc. Soc. Exp. Biol. Med., 137, 29, 1971.
285. Chirigos, M. A., Utility of leukemia viruses for testing antiviral agents in vivo, Ann. N.Y. Acad. Sei., 130, 56, 1965.
286. Farnsworth, W. R., Svoboda, G. H., and Blomster, R. N., Antiviral activity of selected Catharanthus alkaloids, J. Pharm. Sei., 57, 2174, 1968.
287. Sethi, M. L., Comparison of inhibition of reverse transcriptase and antileukemic activities exhibited by protoberberine and benzophenanthridine alkaloids and structure-activity relationships, Phytochemistry, 24, 447, 1985.
288. Sethi, M. L., Enzyme inihibition VIII: mode of inhibition of reverse transcriptase activity by analogues, isomers, and related alkaloids of coralyne, J. Pharm. Sei., 74, 889, 1985
289. Kakiuchi, N., Hattori, M., Ishii, H., and Namba, T., Effect of benzo[c]phenanthridine alkaloids on reverse transcriptase and their binding property to nucleic acids, Planta Med., 53, 22, 1987.
290. Bohlman, F. T., Burkhard, T., and Zdero, C., Naturally Occurring Acetylenes, Academic Press, London, 1973.
291. Towers G. H. N., Photosensitizers in plants and their photodynamic action (a review), Prog. Phytochem., 6, 183, 1980.
292. Towers G. H. N., Interactions of light with phytochemicals in some natural and novel systems, Can. J. Bot., 62, 2900, 1984.
293. Hansen, L. and Boll, P. M., Polyacetylenes in Araliaceae: their chemistry, biosynthesis and biological significance, Phytochemistry, 25, 285, 1986.
294. Lam, J., Breteler, H., and Arnason, J. T., Eds., Chemistry and Biology of Naturally Occurring Acetylenes and Related Compounds, Elsevier Science, Amsterdam, 1988.
295. Marchant, Y. Y., Polyacetylenes, from Bidens, Ph.D. thesis, University of British Columbia, Vancouver, 1985.
296. Ferreira, Z. S. and Gottlieb, O. R., Polyacetylenes as systematic markers in Dicotyledons, Biochem. Syst. Ecol., 10, 155, 1982.
297. Gommers, F. J., Increase of the nematocidal activity of a-terthienyl and related compounds by light, Nematologica, 18, 458, 1972.
298. Arnason, T., Wat, C. K., Downum, K., Yamamoto, E., Graham, E. A., and Towers G. H. N., Photosensitization of E. coli and S. cerevisiae by phenylheptatriyne form Bidens pilosa L, Can. J. Microb., 26, 698, 1980.
299. Gong, H.-H, Kagan, J., Seitz, R., Stokes, A. B., Meyer, F. A., and Tuveson, R. W., The phototoxicity of phenylheptatriyne: oxygen-dependent hemolysis of human erythrocytes and inactivation of Escherichia coli, Photochem. Photobiol., 47, 55, 1988.
300. Kagan, J., Tadema-Wielandt, K., Chan, G., Dhawan, S. W., Jaworksi, J., Pakash, I., and Arora, S. K., Oxygen requirement for near-UV mediated cytotoxicity of phenylheptatriyne to Escherichia coli, Photochem. Photobiol., 39, 465, 1984.
301. Towers G. H. N., Abramowski, Z., Finlayson, A. J., and Zucconi, A., Antibiotic properties of thiarubrine A, a naturally occurring dithiacyclohexadiene polyine, Planta Med., 51, 225, 1985.
302. Arnason, J. T., Philogene, B. J. R., Morand, P., Scaiano, J. C., Werstiuk, N., and Lam, J., Thiophenes and acetylenes: phototoxic agents to herbivorous and blood-feeding insects, in Light Activated Pesticides, American Chemical Society, 1987.
303. McRae, D. G., Yamamoto, E., and Towers G. H. N., The mode of action of polyacetylenes and thiophene photosensitizers on liposome permeability to glucose, Biochim. Biophys. Acta, 821, 488, 1985.
304. Downum, K. R., Hancock, R. E., and Towers G. H. N., Photodynamic action on Escherichia coli of natural acetylenic thiophenes, particularly 5-(buten-l-ynyl)-2,2'-bithienyl, Photobiochem. Photobiophys., 6, 145, 1983.
305. Tuveson, R. W., Kagan, J., Shaw, M. A., Moresco, G. M., Behne, E. M., Pu, H., Bazin, M., and Santus, R., Phototoxic effects of fluoranthene, a polycyclic aromatic hydrocarbon, on bacterial species, Environ. Mol. Mutagen., 10, 245, 1987.
306. Hudson, J. B. and Towers G. H. N., Antiviral properties of photosensitizers, Photochem. Photobiol., 48,289, 1988.
307. Warren, R. A., Hudson, J. B., Downum, K. R., Graham, E. A., Norton, R., and Towers G. H. N., Bateriophages as indicators of the mechanism of action of photosensitizing agents, Photobiochem. Photobiophys., 1, 385, 1980.
308. Hudson, J. B., Graham, E. A., and Towers G. H. N., Nature of the interaction between the photoactive compound phenylheptatriyne and animal viruses, Photochem. Photobiol., 36, 181, 1982.
309. Hudson, J. B., Graham, E. A., and Towers G. H. N., Investigation of the antiviral action of the photoactive compound phenylheptatriyne, Photochem. Photobiol., 43, 27, 1986.
310. Lee, T. Y., Park, S. N., and Lee, J. W., Panaxyne A, a new active principie occurred in Panax ginseng C.A. Meyer. Science Ed. (Seoul Natl. University), 9, 285, 1984.
311. Hudson, J. B. and Lee, T.-Y., unpublished results.
312. Wat, C. K., Biswas, R. K., Graham, E. A., Bohn, L., Towers G. H. N. and Waygood, E. R., Ultraviolet mediated cytotoxic activity of phenylheptatriyne from Bidens alba, J. Natl. Prod., 42, 103, 1979.
313. Arnason, T., Stein, J. R., Graham, E. A., Wat, C. K., Towers G. H. N. and Lam, J., Phototoxicity to selected marine and freshwater algae of polyacetylenes from species in the Asteraceae, Can. J. Bot., 59, 54, 1981.
314. Arnason, T., Swain, T., Wat, C. K., Graham, E. A., Partington, S., Towers G. H. N., and Lam, J., Mosquito larvicidal activity of polyacetylenes from species inthe Asteraceae, Biochem. Syst. Ecol., 9,63,1981.
315. Wat, C. K., MacRae, W. D., Yamamoto, E., Towers G. H. N., and Lam, J., Phototoxic effects of naturally occurring polyacetylenes and a-terthienyl on human erythrocytes, Photochem. Photobiol., 32, 167, 1980.
316. Weir, D., Scaiano, J. C., Arnason, J. T., and Evans, T., Photochemistry of the phototoxic polyacetylene phenylheptatriyne. Photochem. Photobiol., 42, 223, 1985.
317. MacRae, W. D., Yamamoto, E., and Towers G. H. N., unpublished results.
318. Arnason, J. T., Effect of naturally-occurring acetylenes and thiophenes on plant pests, in Chemistry and Biology of Naturally-Occurring Acetylenes and Related Compounds, Lam, J., Breteler, H., and Arnason, J. T., Eds., Elsevier Science, Amsterdam, 1988.
319. Hudson, J. B. and Towers G. H. N., Antiviral properties of actylenes and thiophenes, in Chemistry and Biology ofNaturally-Occurring Acetylenes and Related Compounds, Lam, J., Breteler, H.. and Arnason, J. T., Eds., Elsevier Science, Amsterdam, 1988.
320. Hudson, J. B., Towers G. H. N., Abramowski, Z., Hudson, L., Rossi, R., Carpita, A., and Neri, D., Ultraviolet-mediated antibiotic activity of synthetic thiophenes and their acetylenic derivatives, Chemosphere, in press.
321. Norton, R. A. and Hudson, J. B., unpublished observations.
322. Norton, R. A., Finlayson, A. J., and Towers G. H. N., Two dithiacyclohexadiene polyacetylenes from Chaenactis douglasii and Eriophyllum lanatum, Phytochemistry, 24, 256, 1985.
323. Rodriguez, E., Aregullin, M., Uehara, S., Nishida, T., Wrangham, R., Abramowski, Z., Finlayson, A., and Towers G. H. N., Thiarubrine A, a bioactive constituent of Aspilia (Asteraceae) consumed by wild chimpanzees, Experientia, 41, 419, 1985.
324. Hudson, J. B., Graham, E. A., Miki, N., Hudson, L., and Towers G. H. N., Antiviral activity of the photoactive thiophene a-terthienyl, Photochem. Photobiol., 44, 477, 1986.
325. Hudson, J. B., Graham, E. A., Chan, G. C., and Towers G. H. N., Differential effects of photoactive furanyl compounds on virus functions, Photochem. Photobiol., 42, 523, 1985.
326. Uhlenbroek, G. H. and Bijloo, J. D., Investigation on nematocides. III. Polythienyls and related compounds, Rev. Trav. Chim. PaysBas., 79, 1181, 1960.
327. Arnason, J. T., Philogene, B. J. R., Berg, C., MacEarchern, A., Kaminski, J., Leitch, L. C., Morand, P., and Lam, J., Phototoxicity of naturally-occurring and synthetic thiophenes and acetylene analogues to mosquito larvae, Phytochemistry, 25, 1609, 1986.
328. Hudson, J. B., Graham, E. A., Fong, R., Finlayson, A. J., and Towers G. H. N., Antiviral properties of Thiarubrine A, a naturally occurring polyine, Planta Med., 1,51, 1986.
329. Bakker, J., Gommers, F. J., Nieuwenhuis, I., and Wynberg, H., Photoactivation of the nematicidal compound a-terthienyl from roots of marigolds (Tagetes). A possible singlet oxygen role, J. Biol. Chem., 254, 1841, 1973.
330. Gommers, F. J., Bakker, J., and Smits, L., Effects of singlet oxygen generated by the nematicidal compound, a-terthienyl from Tagetes on the nematode Aphelenchus avenae, Nematologica, 26, 369, 1980.
331. Garcia, F. J., Yamamoto, E., Abramowski, Z., Downum, K., and Towers G. H. N., Comparison of the phototoxicity of a-terthienyl with that of a selenium and of an oxygen analogue, Photochem. Photobiol., 39, 521, 1984.
332. MacRae, W. D., Irwin, D. A., Bisalputra, T., and Towers G. H. N., Membrane lesions in human erythrocytes induced by the naturally occumng compounds a-terthienyl and phenylheptatriyne, Photobio- chem. Photobiophys., 1, 309, 1980.
333. Harborne, J. B., Phytochemical Methods, Chapman and Hall, London, 1973.
334. Robinson, T., The Organic Constituents of Higher Plants, 5th ed., Cordus Press, North Amherst, MA, 1983.
335. Harbourne, J. B., Ed., The Flavonoids, Advances in Research Since 1980, Chapman and Hall, London, 1988.
336. Saini, K. S. and Ghosal, S, Naturally occurring flavans unsubstituted in the heterocyclic ring, Phytochemistry, 2415, 1984.
337. Veckenstedt, A., Beladi, I., and Mucsi, I., Effect of treatment with certain flavonoids on mengo-virus induced encephalitis in mice, Arch. Virol., 57, 255, 1978.
338. Vanden Berghe, D. A., Vlietinck, A. J., and Van Hoof, L., Present status and prospects of plant products as antiviral agents, in Advances in Medicinal Plant Research, Vlietinck, A. J. and Dommisse, Eds., Wissen- schaftliche, Verlagsgesellschaft MbH, Stuttgart, 1985.
339. Vanden Berghe, D. A., Vlietinck, A. J., and Van Hoof, L., Plant products as potential antiviral agents, Buli. Inst. Pasteur, 84, 101, 1986.
340. Giittner, J., Veckenstedt, A., Heinecke, H., and Pusztai, R., Effect of Quercetin on the course of mengovirus infection in immunodeficient and normal mice. A histologic study, Acta Virol., 26, 148, 1982.
341. Beladi, I., Pusztai, R., Mucsi, I., Bakay, M., and Gabor, M., Activity of some flavonoids against viruses, Ann. N.Y. Acad. Sei., 284, 358, 1977.
342. Ishitsuka, H., Ohsawa, C., Ohiwa, T., Umeda, I., and Suhara, Y., Antipicomavirus flavone Ro 09-0179, Antimicrob Agents Chemother., 22, 611, 1982.
343. Rossmann, M. G., The evolution of RNA viruses, Bioessays, 7, 99, 1987.
344. Van Hoof, L., Vanden Berghe, D. A., and Vlietinck, A. J., 3-Methoxy flavones from Euphorbia grantii Oliver as potent recovering agents of virally induced block of host cell synthesis, Arch. Inst. Physiol. Biochem., 92, BI 10, 1984.
345. Van Hoof, L., Vanden Berghe, D. A., Hatfield, G. M., and Vlietinck, A. J., Plant antiviral agents. V. 3-methoxyflavones as potent inhibitors of virus-induced block of cell synthesis, Planta Med., 50,513,1984.
346. Vrijsen, R., Rombout, B., Van Hoof, L., Vanden Berghe, D. A., and Boeye, A., 3-Methylquercetin, an inhibitor of the early stages of poliovirus replication, Arch. Inst. Physiol. Biochem., 92, BI 13, 1984.
347. Vrijsen, R., Everaert, L., Van Hoof, L. M., Vlietinck, A.J., Vanden Berghe, D. A., and Boeye, A., The poliovirus-induced shut-off of cellular protein synthesis persists in the presence of 3-methylquercetin, a flavonoid which blocks virai protein and RNA synthesis, Antiviral Res., 7, 35, 1987.
348. Kaul, T. N., Middleton, E., and Ogra, P. L., Antiviral effect of flavonoids on human viruses, J. Med. Virol., 15,71, 1985.
349. Tsuchiya, Y., Shimizu, M., Himaya, Y., Itoh, K., Hashimoto, Y., Nakayama, M., Horie, T., and Morita, N., Antiviral activity of natural occurring flavonoids in vitro, Chem. Pharm. Buli, 33, 3881, 1985.
350. Konig, B. and Dustmann, J. H., The caffeoylics as a new family of natural antiviral compounds, Naturwissenschaften, 72, 659, 1985.
351. Castrillo, J. L. and Carrasco, L., Action of 3-methylquercetin on poliovirus RNA replication, J. Virol., 61, 3319, 1987.
352. Vrijsen, R., Everaert, L., and Boeye, A., Antiviral activity of flavones and potentiation by ascorbate, J. Gen. Virol., 69, 1749, 1988.
353. Ishitsuka, H., Ninomiya, Y., Ohsawa, C., Fujiu, M., and Suhara, Y., Direct and specific inactivation of rhinovirus by Chalcone Ro 09-410, Antimicrob. Agents Chemother., 22, 617, 1982.
354. Ninomiya, Y., Ohsawa, C., Aoyama, M., Uneda, I., Suhara, Y., and Ishitsuka, H., Antiviral agent, Ro 09410, binds to rhinovirus specifically and stabilizes the virus confomation, Virology, 134, 269, 1984.
355. Phillpotts, R. J., Higgins, P. G., Willman, J. S., Tyrrell, D. A. J., and Lennox-Smith, I., Evaluation of the antirhinovirus chalcone Ro 09-415 given orally to volunteers, J. Antimicrob. Chemother., 14, 403, 1984.
356. Ahmad, A. L. M., Dowsett, A. B., and Tyrrell, D. A. J., Studies of rhinovirus resistant to an antiviral chalcone, Antiviral Res., 8, 27, 1987.
357. Bauer, D. J., Selway, J. W. T., Batchelor, J. F., Tisdale, M., Caldwell, I. C., and Young, D. A. B., 4',6 Dichloroflavan (BW683c) a new antirhinovirus compound, Nature, 292, 369, 1981.
358. Tisdale, M. and Selway, J. W. T., Inhibition of an early stage of rhinovirus replication by dichloroflavan (BW683c), J. Gen. Virol., 64,795,1983.
359. Tisdale, M. and Selway, J. W. T., Effect of dichloroflavan (BW683c) on the stability and uncoating of rhinovirus type 1B, J. Antimicrob. Ther., 14 (suppl.A), 97, 1984.
360. Phillpotts, R. J., Wallace, J., Tyrrell, D. A. J., Freestone, D. S., and Shepherd, W. M., Failure of oral 4',6- dichloroflavan to protect against rhinovirus infection in man, Arch. Virol., 75, 115, 1983.
361. Bauer, D. J. and Selway, J. W. T., A novel method for detecting the antiviral activity of flavans in their vapour phase, Antiviral Res., 3, 235, 1983.
362. Ninomiya, Y., Aoyama, M., Umeda, I., Suhara, Y., and Ishitsuka, H., Comparative studies on the modes of action of the 4',6-dichloroflavan and enviroxime, Antimicrob. Agents Chemother., 27,595,1985.
363. Smith, T. J., Kremer, M. J., Luo, M., Vriend, G., Arnold, E., Kamer, G., Rossmann, M. G., McKinlay, M. A., Diana, G. D., and Otto, M. J., The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating, Science, 233, 1286, 1986.
364. Apple, M. A., Fischer, P., Wong, W., Pagarelli, J., Harasymiv, I., and Osofsky, L., Inhibition of oncomavirus reverse transcriptase by plant flavonols, Am. Assoe. Cancer Res. Abstr., 16, 198, 1975.
365. Robinson, T., The Organic Constituents of Higher Plants, Cordus Press, North Amherst, MA, 1983.
366. Sinsheimer, J. E., Subba Rao, G., Mcllheny, H. M., Smith, R. V., Maasab, H. F., and Cochran, K. W., Isolation and antiviral activity of the gymnemic acids, Experientia, 24, 302, 1968.
367. Subba Rao, G., Sinsheimer, J. E., and Cochran, K. W., Antiviral activity of triterpenoid saponins containing acylated P-amyrin aglycones, J. Pharm. Sei., 63, 471, 1974.
368. Pompei, R., Flore, O., Marccialis, M. A., Pani, A., and Loddo, B., Glycyrrhizic acid inhibits virus growth and inactivates virus particles, Nature, 281, 689, 1979.
369. Ito, M., Nakashima, H., Baba, M., Pauwels, R., DeClercq, E., Shigeta, S., and Yamamoto, N., Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus (HIV), Antiviral Res.. 7, 127, 1987.
370. Vanden Berghe, D. A., Vlietinck, A. J., and Van Hoof, L., Plant products as potential antiviral agents. Buli. Inst. Pasteur, 84, 101, 1986.
371. Baba, M. and Shigeta, S., Antiviral activity of glycyrrhizin against varicella zoster virus in vitro, Antiviral Res.,7, 99, 1987.
372. Amoros, M., Faucounier, B., and Girre, R. L., In vitro antiviral activity of a saponin from Anagallis arvensis, Primulaceae, against herpes simplex virus and poliovirus, Antiviral Res., 8, 13, 1987.
373. Dargan, D. J. and Subak-Sharpe, J. H., The effect of triterpenoid compounds on uninfected and herpes simplex virus infected cells in culture. I. Effect on cell growth, virus particles and virus replication, J. Gen. Virol., 66, 1771, 1985.
374. Dargan, D. J. and Subak-Sharpe, J. H., The effect of triterpenoid compounds on uninfected and herpes simplex virus infected cells in culture. II. DNA and protein synthesis, polypeptide processing and transplantation, J. Gen. Virol., 67, 1831, 1986.
375. Dargan, D. J. and Subak-Sharpe, J. H., The effect of triterpenoid compounds on uninfected and herpes simplex virus infected cells in culture. III. Ultrastructural study of virion maturation, J. Gen. Virol., 69, 439, 1988.
376. Morein, B., Sundquist, B., Hõglund, S., Dalsgaard, K., and Osterhaus, A., Iscom, a novel strueture for antigenic presentation of membrane protein from enveloped viruses, Nature, 308, 457, 1984.
377. Amoros, M., Fauconnier, B., and Girre, R. L., Effect of saponins from Anagallis arvensis on experimental herpes simplex keratitis in rabbits, Planta Med., 54, 128, 1988.
378. Poswillo, D. E. and Roberts, G. J., Topical carbenoxalone for orofacial herpes simplex infection, Lancet, 2, 143, 1981.
379. Abe, N., Ebina, T., and Ishida, W., Interferon induetion by glycyrrhizin and glycyrrhetinic acid in mice, Microbiol. Immunol., 26, 535, 1982.
380. Singh, V. K., George, C. X., Singh, N., Agarwal, S. S., and Gupta, B. M., Combined treatment of mice with Panax ginseng extract and interferon inducer, Planta Med., 47, 234, 1983.
381. Singh, V. K., Agarwal, S. S., and Gupta, B. M., Immunomodulatory activity of Panax ginseng extract, Planta Med., 48, 462, 1984.
382. Campbell, J. B., Maharaj, I., and Roith, J., Vaccine formulation for oral immunization of laboratory animais and wildlife against rabies, in Rabies in the Tropics, Kuwert, E., Ed., Springer-Verlag, Heidelberg, 1985, 285.
383. Morein, B. and Simon, K., Subunit vaccines against enveloped viruses: virosomes, micelles and other protein complexes, Vaccine, 3, 83, 1985.
384. Maharaj, I., Froh, K. J., and Campbell, J. B., Immune responses of mice to inactivated rabies vaccine administered orally: potentiation by Quillaja saponin, Can. J. Microbiol., 32, 414, 1986.
385. Chavali, S. R. and Campbell, J. B., Adjuvant effects of orally administered saponins on humoral and cellular immune reponses in mice, Immunobiology, 174, 347, 1987.
386. Chavali, S. R. and Campbell, J. B., Immunomodulatory effects of orally-administered saponins and non- specific resistance against rabies infection, Int. Arch. Allergy Appl. Immunol., in press.
387. Chavali, S. R., Francis, T., and Campbell, J. B., An in vitro study of immunomodulatory effects of some saponins, Int. J. Immunopharmacol., in press.
388. Yeung, H. W., Cheung, K., and Leung, K. N., Immunopharmacology of Chinese medicine 1, ginseng induced immunosuppression in virus infected mice, Am. J. Chinese Med., X, 1, 1982.
389. Koch, A., and Gyõrgy, E., Heart glycosides in poliovirus host cell interaction. I. Acta Microbiol. Acad. Sei. Hung., 16, 189, 1969.
390. Gyõrgy, E. and Koch, A., Heart glycosides in poliovirus host cell interaction. II. Acta Microbiol. Acad. Sei. Hung., 16, 197, 1969.
391. Link, F., Szanto, J., Blastovic, D., Raus, J., Dobrocka, E., and Pistasova, S., Acta Virol., 10, 455, 1966.
392. Tomita, Y. and Kuwata, T., Suppression of murine leukemia virus production by ouabain and interferon in mouse cells, J. Gen. Virol., 38, 223, 1978.
393. McDonald, I. F., Sachs, H. G., Orr, C. W. M., and Ebert, J. D., Multiple effects of Ouabain on BHK cells, Exp. Cell Res., 74, 201, 1972.
394. Dorsett, P. W., Kerstine, E. E., and Powers, L. J., Antiviral activity of gossypol and apogossypol, J. Pharm. Sei., 64, 1073, 1975.
395. Wichmann, K., Vaheri, A., and Luukkainen, T., Inhibiting herpes simplex virus type 2 infection in human epithelial cells by gossypol, a potent spermicidal and contraceptive agent, Am. J. Obstet. Gynecol., 142, 593, 1982.
396. Radloff, R. J., Deck, L. M., Boyer, R. E., and Vander Jagt, D. L., Antiviral activities of gossypol and its derivatives against HSV type II, Pharmacol. Res. Commun., 18, 1063, 1986.
397. Renis, H. E., In vitro antiviral activity of calcium elenolate, Antimicrob. Agents Chemother., 167, 1969.
398. Renis, H. E., Inactivation of myxoviruses by calcium elenolate, Antimicrob. Agents Chemother., 8, 194, 1975.
399. Soret, M. G., Antiviral activity of calcium elenolate on parainfluenza infection of hamsters, Antimicrob. Agents Chemother., 160, 1969.
400. Elliot, G. A., Buthala, D. A., and DeYoung, E. N., Preliminary safety studies with calcium elenolate, an antiviral agent, Antimicrob. Agents Chemother., 173, 1969.
401. Blevins, R. D. and Dumic, M. P., The effect of delta-9-tetrahydro-cannabinol on herpes simplex virus replication, J. Gen. Virol., 49, 427, 1980.
402. Cabral, G. A., McNerny, P. J., and Mishkin, E. M., Delta-9-tetrahydrocannabinol enhancer release of herpes simplex virus type 2, J. Gen. Virol., 67, 2017, 1986.
403. Cabral, G. A., Mishkin, E. M., and Hosapple, M. P., Delta-9-tetrahydrocannabinol decreases host resistance to herpes simplex virus type 2 vaginal infection in the guinea-pig, Marihuana’84: Proc. Oxford Symposium on Cannabis, Harvey, D. J., Ed., IRL Press, Oxford, 1985, 471.
404. Mishkin, E. M. and Cabral, G. A., Delta-9-tetrahydrocannabinol decreases host resistance to herpes simplex virus type 2 vaginal infection in the B6C3F1 mouse, J. Gen. Virol., 66, 2539, 1985.
405. MacRae, W. D. and Towers G. H. N., Biological activities of lignans, Phytochemistry, 23, 1207, 1984.
406. Rao, C. B. S., Ed., Chemistry of Lignans, Andrha University Press, índia, 1978.
407. Bedows, E. and Hatfield, G. M., An investigation of the antiviral activity of Podophyllum peltatum, J. Natl. Prod., 45,725, 1982.
408. Markkanen, T., Makinen, M. L., Nikoskelainen, J., Ruohonen, J., Nieminen, K., Jokinen, P., Raunio, R., and Hirvonen, T., Antiherpetic agent from juniper tree (Juniperus communis), its purification, identification and testing in primary human amnion cell cultures, Drugs Exp. Clin. Res., VII, 691, 1981.
409. Markkanen, T., Mãkinen, M. L., Maunuksela, E., and Himanen, P., Podophyllotoxin lignans under experimental antiviral research, Drugs Exp. Clin. Res., VII, 711, 1981.
410. MacRae, W. D., Hudson, J. B., and Towers G. H. N., Studies on the pharmacological activity of Amazonian Euphorbiaceae, J. Ethnopharmacol., 22, 143, 1988.
411. MacRae, W. D., Hudson, J. B., and Towers G. H. N., α(-)peltatin, an antiviral constituent of Amanoa aff. oblongifolia, J. Ethnopharmacol, 22, 223, 1988.
412. MacRae, W. D., Hudson, J. B., and Towers G. H. N., The antiviral action of lignans, Planta Med., in press.
413. Vanden Berghe, D. A., Vlietinck, A. J., and Van Hoof, L., Plant products as potential antiviral agents, Buli. Inst. Pasteur, 84, 101, 1986.
414. Munakata, K., Maruno, S., and Ohta, K., Justicidin A and B, the fish-killing components of Justicia hayatai var. decumbens, Tetrahedron Lett., 47, 4167, 1965.
415. Hudson, J. B., Further studies on the mechanism of centrifugal enhancement of cytomegalovirus infectivity, J. Virol. Meth., 19, 97, 1988.
416. Mizel, S. B. and Wilson, L., Nucleoside transport in mammalian cells inhibited by colchicine, Biochemistry, 2573, 1972.
417. Loike, J. D. and Horowitz, S. B., Effect of VP-16-213 on the intracellular degradation of DNA inHela cells, Biochemistry, 15, 5443, 1976.
418. Loike, J. D. and Horowitz, S. B., Effect of podophyllotoxin and VP-16-213 on microtubule assembly in vitro and nucleotide transport in Hela cells, Biochemistry, 15, 5435, 1976.
419. Kõnig, B. and Dustmann, J. H., The caffeoylics as a new family of natural antiviral compounds, Naturwis- senschaften, 72, 659, 1985.
420. Vanden Berghe, D. A., Vlietinck, A. J., and Van Hoof, L., Plant products as potential antiviral agents, Buli. lnst. Pasteur, 84, 101, 1986.
421. Thiel, K. D., Helbig, B., Sprôssig, M., Klôning, R., and Wutzler, P., Antiviral activity of enzymatically oxidized caffeic acid against herpesvirus hominis type 1 and type 2, Acta Virol., 27, 200, 1983.
422. Sydow, G., Wunderlich, V., Klôning, R., and Helbig, B., Zur Wirkung von phenolkõperpolymerisaten auf retroviren (effect of phenolic polymers on retroviruses), Pharmazie, 41, 865, 1986.
423. Kucera, L. S. and Herrmann, E. C., Antiviral substances of plants of the mint family (Labiateae). I. Tannin of Melissa officinalis, Proc. Soc. Exp. Biol. Med.,124, 865, 1967.
424. Kucera, L. S. and Herrmann, E. C., Antiviral substances of plants of the mint family (Labiateae). II. Non- tannin polyphenols, Proc. Soc. Exp. Biol. Med.,124, 870, 1967.
425. Herrmann, E. C. and Kucera, L. S., Antiviral substances of plants of the mint family (Labiateae). III. Peppermint (Mentha piperita) and other mint plants, Proc. Soc. Exp. Biol. Med., 124, 874, 1967.
426. Konowalchuk, J. and Speirs, J. I., Virus inactivation by grapes and wines, Appl. Environ. Microbiol., 32,757, 1976.
427. Konowalchuk, J. and Speirs, J. I., Antiviral activity of fruit extracts, J. Food Sei., 41, 1013, 1976.
428. Konowalchuk, J. and Speirs, J. I., Antiviral effect of commercial juices and beverages, Appl. Environ. Microbiol., 35, 1219, 1978.
429. Takechi, M. and Tanaka, Y., Purification and characterization of antiviral substance from the bud of Syzygium aromatica, Planta Med., 42, 69, 1981.
430. Goodwin, T. W. and Mercer, E. I., Introduction to Plant Biochemistry, 2nd ed., Pergamon Press, 1983, chap. 14.
431. Kochman, M., Mastalertz, P., and Inglot, A. D., Inhibiton of encephalomyocarditis virus replication by simple phenolic and carboxylic acids, Nature, 207, 888, 1965.
432. Seifter, E., Rettura, G., Levenson, S. M., and Appleman, M., and Seifter, J., Aspirin inhibits a murine virai infection, Life Sei., 16, 629, 1975.
433. White, R. F., Acetylsalicylic acid (aspirin) induces resistance to tobacco mosaic virus in tobacco, Virology, 99,410, 1979.
434. Pennazio, S., Roggero, P., and Lenzi, R., Resistance to tobacco necrosis virus induced by salicylate in detached tobacco leaves, Antiviral Res., 3, 335, 1983.
435. Antoniw, J. F., Ritter, C. E., Pierpoint, W. S., and Van Loon, L. C., Comparison of three pathogenesis- related proteins from plants of two cultivars of tobacco infected with TMV, J. Gen. Virol., 47, 79, 1980.
436. Satyavati, G. V. and Gupta, A. K., Eds., Medicinal Plants of Índia: Volume 2, Indian Council of Medicai Research, New Delhi, 1987, 56.
437. Meruelo, D., Lavie, G., and Lavie, D., Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin, Proc. Natl. Acad. Sei. U.S.A., 85, 5230, 1988.
438. Schuerch, A. R. and Wehrli, W., 3-lapachone, an inhibitor of Oncomavirus reverse transcriptase and eukaryotic DNA polymerase-oe, Eur. J. Biochem., 84, 197, 1978.
439. Joshi, K. C., Singh, P., Pardasani, R. T., and Singh, G., Quinones and other constituents from Haplo- phragma adenophyllum. Planta Med., 37, 60, 1979.
440. Irvin, J. D., Pokeweed antiviral protein, Pharmacol. Ther., 21, 371, 1983.
441. Lord, J. M. and Roberts, L. M., Plant toxins, Microbiol. Sei., 4, 376, 1987.
442. Ragetli, H. W. J. and Weintraub, M., Purification and characteristics of a virus inhibitor from Dianthus caryophyllus L, Virology, 18, 232, 1962.
443. Grasso, S. and Shepherd, R., Isolation and pardal characterization of virus inhibitors from plant species taxonomically related to Phytolacca, Phytopathology, 68, 199, 1978.
444. Stirpe, F., Olsnes, S., and Pihl, A., Gelonin, a new inhibitor of protein synthesis, nontoxic to intact cells, isolation, characterization, and preparation of cytotoxic complexes with concanavalin A, J. Biol. Chem., 255, 6947, 1980.
445. Teltow, G. J., Irvin, J. D., and Aron, G. M., Inhibition of herpes simplex virus DNA synthesis by pokeweed antiviral protein, Antimicrob. Agents. Chemother., 23, 390, 1983.
446. Stevens, W. A., Spurdon, C., Onyon, L. J., and Stirpe, F., Effects of inhibitors of protein synthesis from plants on tobacco mosaic virus infection, Experientia, 37, 257, 1981.
447. Hino, M., Sekizawa, T., and Openshaw, H., Ricin injection eliminates latent herpes simplex virus in the mouse, J. Infect. Dis., 157, 1270, 1988.
448. Ito, M., Girvin, L., and Barron, A. L., Inactivation of human cytomegalovirus by phytohemagglutinin, Arch. Virol., 57, 97, 1978.
449. Okada, Y. and Kim, J., Interaction of concanavalin A with enveloped viruses and host cells, Virology, 5,507, 1972.
450. McClain, D. A. and Edelman, G. L., Analysis of the stimulation-inhibition paradox exhibited by lymphocytes exposed to concanavalin A, J. Exp. Med., 144, 1494, 1976.
451. Hudson, J. B., unpublished results.
452. Robinson, W. E., Montefiore, D. C., and Mitchell, W. M., Evidence that mannosyl residues are involved in human immunodeficiency virus type 1 (HIV-1) pathogenesis, AIDS Res. Hum. Retrov., 3, 265, 1987.
453. Antignus, Y., Sela, I., and Harpas, I., Further studies on the biology of an antiviral fator (AVF) from virus- infected plants and its association with the N-gene of Nicotiana species, J. Gen. Virol., 35, 107, 1977.
454. Mozes, R., Antignus, Y., Sela, I., and Harpaz, I., The chemical nature of an antiviral factor (AVF) from virus- infected plants, J. Gen. Virol., 38, 241, 1978.
455. Babbar, O. P., Bajpai, S. K., Chowdhury, B. L., and Khan, S. K., Occurrence of interferon-like antiviral and antitumor fators(s) in extracts of some indigenous plants, Ind. J. Exp. Biol., 17, 451, 1979.
456. Wachsman, M., Martino, V., Gutkind, G. O., Coussio, J. D., Coto, C. E., and de Torres, R. A., Antiviral activity of a Melia azedarach plant extract, Fitoterapia, 53, 167, 1982.
457. Wachsman, M. B., Damonte, E. B., Coto, C. E., and de Torres, R. A., Antiviral effects of Melia azedarach L. leaves extracts on Sindbis virus-infected cells, Antiviral Res., 8, 1, 1987.
458. Andrei, G. M., Damonte, E. B., de Torres, R. A., and Coto, C. E., Induction of a refractory state to virai infection in mammalian cells by a plant inhibitor isolated from leaves of Melia azedarach L., Antiviral Res., 57, 1988.
459. Andrei, G. M., Lampuri, J. S., Coto, C. E., and de Torres, R. A., An antiviral factor form Melia azedarach L. prevents Tacaribe virus encephalitis in mice, Experientia, 42, 843, 1986.
460. Claus, J., Andrei, G., Coto, C. E., and de Torres, R. A., HSV-1 intraperitoneal infection of Balb/c mice: effect of treatment with Melia azedarach green leaf extract, 2nd Int. Conf. on the Impact of Virai Diseases on the development of Latin American countries and the Caribbean region, Mar del Plata, Argentina, March 1988, Abstr. PS2-8.
461. Zhirnov, O. P., Ovcharenko, A. V., and Bukrinskaya, A. G., Myxovirus replicaton in chicken embryos can be suppressed by aprotinin due to the blockage of virai glycoprotein cleavage, J. Gen. Virol., 66, 1633, 1985.
462. Nicolaides, E., De Wald, H., Westland, R., Lipnik, M., and Posler, J., Potential antiviral agents. Carbobenzoxy di- and tri-peptides active against measles and herpes viruses, J. Med. Chem., 11, 74, 1968.
463. Miller, F. A., Dixon, G. J., Arnett, G., Dice, J. R., Rightsell, W. A., Schabel, F. M., and McLean, I. W., Antiviral activity of carbobenzoxy di- and tri-peptides on measles virus, Appl. Environ. Microbiol., 16, 1489, 1968.
464. Norrby, E., The effect of a carbobenzoxy tripeptide on the biological activities of measles virus, Virology, 44, 599, 1971.
465. Choppin, P. W., Richardson, C. D., and Scheid, A., Analogues of virai polypeptides which specifically inhibit virai replication, in Problems of Antiviral Therapy, Stuart-Harris, C. H. and Oxford, J., Eds., Academic Press, New York, 1983.
466. Gaudreau, P., Michaud, J., Cohen, E. A., Langelier, Y., and Brazeau, P., Structure activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reduetase, J. Biol. Chem., 262, 1 2413, 1987.
467. Epand, R. M., Lobl, T. J., and Renis, H. E., Bilayer stabilizing peptides and the inhibition of virai infection: antimeasles activity of carbobenzoxy-ser-leu-amide, Biosci. Rep., 7, 745, 1987.
468. Docherty, J. J. and Pollock, J. J., Inactivation of herpes simplex virus types 1 and 2 by synthetic histidine peptides, Antimicrob. Agents. Chemother., 31, 1562, 1987.
469. Rinehart, K. L., Gloer, J. B., Hughes, R. G., Renis, H. E., McGovren, J. P., Swynenberg, E. B., Stringfellow, D. A., Kuentzel, S. L., and Li, L. H., Didemnins: antiviral and antitumor depsipeptides from a Caribbean tunicate, Science, 112, 933, 1981.
470. Weed, S. D. and Stringfellow, D. A., Didemnins A and B. Effectiveness against cutaneous herpes simplex virus in mice, Antiviral Res., 3, 269, 1983.
471. McGrath, M. S., Hwang, K. M., Caldwell, S. E., et al., Proc. Natl. Acad. Sei. U.S.A., 86, 2844, 1989.
472. Babbar, O. P., Chowdhury, B. L., Singh, M. P., Khan, S. K., and Bajpai, S., Nature of antiviral activity detected in some plant extracts screened in cell cultures infected with vaccinia and Ranikhet disease viruses, Ind. J. Exp. Biol., 8, 304, 1970.
473. Babbar, O. P., Bajpai, S. K., Chowdhury, B. C., and Khan, S. K., Occurrence of interferon-like antivirals and antitumor factor(s) in extracts of some indigenous plants, Ind. J.Exp. Biol., 17, 451, 1979.
474. Babbar, O. P., Joshi, M. N., and Madan, A. R., Evaluation of plants for antiviral activity, Ind. J. Med. Res., 76(Suppl.), 54, 1982.
475. Bajpai, S. K., Babbar, O. P., Chandra, K., and Verma, H. N., Demonstration of antiviral and antitumor activity in extracts of some plants, Ind. J. Virol., 1, 215, 1985.
476. Wachsman, M. B., Martino, V., Gutkind, G. O., Coussio, J. D., Coto, C. E., and de Torres, R. A., Antiviral activity of a Melia azedarach plant extract, Fitoterapia, 53, 167, 1982.
477. Wachsman, M. B., Martino, V., and Coto, C. E., Search for antiviral activity in high plant extracts, Fitoterapia, in press.
478. MacRae, W. D., Hudson, J. B., and Towers G. H. N., Studies on the pharamacological activity of Amazonian Euphorbiaceae, J. Ethnopharmacol., 22, 143, 1988.
479. MacRae, W. D., Hudson, J. B., and Towers G. H. N., a-Peltatin, an antiviral constituent of Amanoa aff. oblongifolia, J. Ethnopharmacol, 22, 3, 1988.
480. Herrmann, E. C. and Kucera, L. S., Antiviral substances in plants of the mint family (Labiatae). III. Peppermint (Mentha piperita) and other mint plants, Proc. Soc. Exp. Biol. Med., 124, 874, 1967.
481. Konowalchuk, J. and Speirs, J. I., Antiviral activity of fruit extracts, J. Food Sei., 41, 1013, 1976.
482. Konowalchuk, J. and Speirs, J. I., Antiviral effect of commercial juices and beverages, Appl. Environ. Microbiol., 35, 1219, 1978.
483. Farnsworth, W. R., Henry, L. K., Svoboda, G. H., Blomster, R. N., Yates, M. J., and Euler, K. L., Biological and phytochemical evaluation of plants. I. Biological test procedures and results from two hundred accessions, J. Natl. Prod., 29, 101, 1966.
484. Farnsworth, W. R., Henry, L. K., Svoboda, G. H., Blomster, R. N., Fong, H. H., Quimby, M. W., and Yates, M. J., Biological and phytochemical evaluation of plants. II. Test results from an additional two hundred accessions, J. Natl. Prod., 31, 237, 1968.
485. Fong, H. H. S., Farnsworth, N. R., Henry, L. K., Svoboda, G. H., and Yates, M. J., Biological and phytochemical evaluation of plants. X. Test results from a third two-hundred accessions, J. Natl. Prod., 35,35, 1972.
486. Vanden Berghe, D. A., Ieven, M., Mertens, F., and Vlietinck, A. J., Screening of higherplants for biological activities. II. Antiviral activity, J. Natl. Prod., 41, 463, 1978.
487. Van Beck, T. A., Deelder, A. M., Verpoorte, R., and Svendsen, A. B., Antimicrobial, antiamoebic, and antiviral screening of some Tabernaemontana species, Planta Med., 50, 180, 1983.
488. Suganda, A. F., Amoros, M., Girre, L., and Fauconnier, B., Effects inhibiteurs de quelques extraits bruts et semi-purifies des plantes indigenes francaises sur la multiplication de 1 'herpesvirus humain 1 et du poliovirus humain 2 en culture cellulaire, J. Natl. Prod., 46, 626, 1983.
489. Chang, R. S. and Yeung, H. W., Inhibition of growth of human immunodeficiency virus in vitro by crude extracts of Chinese medicinal herbs, Antiviral Res., 9, 163, 1988.
490. Singh, P., Sharma, A. K., Joshi, K. C., and Bohlmann, F., A further dithienylacetylene from Eclipta erecta, Phytochemistry, 24, 615, 1985.
491. Singh, P., Naturally occurring thiophene derivatives from Eclipta species, in Chemistry and Biology of Naturally Occurring Acetylenes and Related Compounds, Lam, J., Breteler, H., and Amason, J. T., Eds., Elsevier Science, Amsterdam, 1988.
492. Hudson, J. B. and Towers G. H. N., Antiviral properties of plant photosensitizers, Photochem. Photobiol., 48, 289, 1988.
493. Thyagarajan, S. P., Thiruneelakantan, K., Subramanian, S., and Sundaravelu, T., In vitro inactivation of HBsAg by Eclipta alba Hassk and Phyllanthus niruri Linn., Ind. J. Med. Res., 76(Suppl.), 124, 1982.
494. Thyagarajan, S. P., Antiviral substance against hepatitis B a possibility, Proc. Natl. Symp. HBV and its Infections Sec. B, 30, 1986.
495. Jarayam, S., Thyagarajan, S. P., Panchanadam, M., and Subramanian, S., Anti-hepatitis B virus properties of Phyllanthus niruri Linn and Eclipta alba Hassk: in vitro and in vivo safety studies, Bio. Med., 7, 1987.
496. Venkateswaran, P. S., Millman, I., and Blumberg, B. S., Effects of an extract from Phyllanthus niruri on hepatitis B and Woodchuck hepatitis viruses: in vitro and in vivo studies, Proc. Natl. Acad. Sei. U.S.A., 84,274, 1987.
497. Zheng, M., An experimental study of antiviral action of 472 herbs on herpes simplex virus, J. Trad. Chinese Med., 8, 203, 1988.
498. Lozoya, X., personal communication.